Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunity. 2008 Apr;28(4):445-53. doi: 10.1016/j.immuni.2008.03.001.

Th17 cell differentiation: the long and winding road.

Author information

1
Schering-Plough Biopharma, 901 California Avenue, Palo Alto, CA 94304, USA. mandy.mcgeachy@spcorp.com

Abstract

The characterization of the new lineage of IL-17-producing CD4+ T helper (Th17) cells has revolutionized our current understanding of T cell-mediated immunity. Over the past five years, there have been many twists and turns as the pathways that lead to Th17 cell differentiation have been elucidated. Not least of these was the discovery that TGF-beta is a crucial cytokine for Th17 cell development, suggesting that Th17 and regulatory T cell subsets share reciprocal developmental pathways during the pathogenesis or control of inflammation. This review aims to bring together the observations that have formed current opinion on factors that promote and contain Th17 cell development, in both mouse and man. Unresolved controversies in this field are also discussed: For example, IL-23 is absolutely required for disease pathogenesis in many models of Th17-cell-mediated autoimmunity, yet its role in Th17 cell development is relatively unclear.

PMID:
18400187
DOI:
10.1016/j.immuni.2008.03.001
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center